A
Aether Biomachines
State of the art platform to rapidly engineer enzymes
About Aether Biomachines
Aether Bio is a cutting-edge biotechnology startup that specializes in engineering enzymes to help its clients manufacture complex and innovative products at a fraction of the usual cost. The company operates in the biotechnology market, serving clients who require specialized enzymes for various chemical processes.
Aether Bio's unique selling proposition lies in its ability to search sequence space to find novel biocatalysts, making it the first company with such capability. This means they can design enzymes for an ever-increasing range of chemistries, all within a client's preferred timeline.
The company's business model is based on its proprietary hardware that allows for massively parallel experimentation. This technology generates data sets that are significantly larger than those of its competitors, providing a competitive edge in the market.
In terms of revenue, Aether Bio makes money by offering its enzyme engineering services to clients. The company is currently selective in taking on new clients, indicating a focus on high-value contracts.
Aether Bio likens its work to how Google mapped the internet, as it maps trillions of enzymes to create a searchable index. This innovative approach has attracted a strong roster of investors who see the potential of Aether Bio's work to trigger a new industrial revolution.
In summary, Aether Bio is a pioneering biotech startup that uses its proprietary technology to engineer enzymes, serving clients in various industries and paving the way for a new industrial revolution.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2017
- Headquarters
- Menlo Park, United States
- Employees
- 91
- Open positions
- 1
- Dealroom signal
- 93.8/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Biotechnology, Catalyst, Tech for Biotech and Pharma, Techbio, Hard Tech, DT and LS, science-based
- Technology
- Hardware, Deep Tech, Autonomous & Sensor Tech
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| GRANTOther financing | Dec 2025 | $28K | — | Basque Government | — |
| GRANTOther financing | Dec 2025 | $28K | — | Provincial Council of Bizkaia | — |
Growth signals
Latest recorded traffic for Aether Biomachines is 6.6K monthly website visits, up 164% over the last three months. Aether Biomachines's team grew 30% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed3 investors entered at this stage
Gaingels
Basque Government
Provincial Council of Bizkaia
Series A10 investors entered at this stage
Jay Zaveri
TREVOR ZIMMERMAN
Tribe Capital
4DX Ventures
Shrug Capital- UMUnless Management
Natural Capital
Henkel
Radicle Impact- RRResilience Reserve
Other known investors3 additional known investors
BEAZ
CITRIS Foundry
Neue Fund
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Aether Biomachines on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Aether Biomachines’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.